Lifevantage Corporation (LFVN)

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

LifeVantage Declares Quarterly Dividend

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and...

LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and...

LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

SALT LAKE CITY, April 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health...

LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas

SALT LAKE CITY, April 20, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health...

Form 8-K - Current report

LifeVantage Appointing Terrence Moorehead as Chief Executive Officer

SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or...

LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026

SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities